Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 15.67% is in line with its 5-year average of 16.06%, around the middle of its 5-year range (11.18%–21.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.53% below its 12-month average of 16.08%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.67%.
DEBT TO ASSETS RATIO
15.67%
DEBT TO ASSETS RATIO AVG TTM
16.08%
DEBT TO ASSETS RATIO AVG 3Y
15.94%
DEBT TO ASSETS RATIO AVG 5Y
16.06%
DEBT TO ASSETS RATIO AVG 10Y
16.39%
DEBT TO ASSETS RATIO AVG 15Y
12.88%
DEBT TO ASSETS RATIO AVG 20Y
9.70%
CURRENT VS TTM AVG
-2.53%
CURRENT VS 3Y AVG
-1.67%
CURRENT VS 5Y AVG
-2.45%
CURRENT VS 10Y AVG
-4.37%
CURRENT VS 15Y AVG
+21.65%
CURRENT VS 20Y AVG
+61.54%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+17311.68%
vs the sector median at left
Savara Inc.
Market Cap
$959.26M
Debt to Assets Ratio
15.67%
TTM Avg
16.08%
3Y Avg
15.94%
5Y Avg
16.06%
Market Cap
$962.35M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$938.65M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$937.88M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$980.03M
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$931.97M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$987.57M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$991.60M
Debt to Assets Ratio
0.28%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Savara Inc. (SVRA) | $959.26M | 15.67% | 16.08% | 15.94% | 16.06% |
| Aktis Oncology, Inc. (AKTS)vs › | $962.35M | 0.02% | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $938.65M | 0.04% | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $937.88M | 0.18% | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $980.03M | 0.33% | N/A | N/A | N/A |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $931.97M | 0.01% | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $931.94M | 0.13% | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $987.57M | 0.01% | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $991.60M | 0.28% | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $992.10M | 0.16% | N/A | N/A | N/A |
Debt/Assets
15.7%
Debt/Equity
0.21
Current Ratio
10.13
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 15.67% |
| 2026-03-31 | 13.59% |
| 2025-12-31 | 11.80% |
| 2025-09-30 | 21.17% |
| 2025-06-30 | 18.16% |
| 2025-03-31 | 15.66% |
| 2024-12-31 | 12.56% |
| 2024-09-30 | 11.18% |
| 2024-06-30 | 19.07% |
| 2024-03-31 | 16.78% |
| 2023-12-31 | 14.92% |
| 2023-09-30 | 14.67% |
| 2023-06-30 | 21.95% |
| 2023-03-31 | 20.26% |
| 2022-12-31 | 18.70% |
| 2022-09-30 | 17.66% |
| 2022-06-30 | 16.61% |
| 2022-03-31 | 15.66% |
| 2021-12-31 | 14.60% |
| 2021-09-30 | 13.71% |
| 2021-06-30 | 12.97% |
| 2021-03-31 | 12.23% |
| 2020-12-31 | 25.87% |
| 2020-09-30 | 23.04% |
| 2020-06-30 | 21.86% |
| 2020-03-31 | 20.87% |
| 2019-12-31 | 18.76% |
| 2019-09-30 | 18.15% |
| 2019-06-30 | 17.32% |
| 2019-03-31 | 17.12% |
| 2018-12-31 | 16.13% |
| 2018-09-30 | 9.94% |
| 2018-06-30 | 12.99% |
| 2018-03-31 | 11.80% |
| 2017-12-31 | 9.61% |
| 2017-09-30 | 12.82% |
| 2017-06-30 | 12.40% |
| 2017-03-31 | 25.40% |
| 2016-12-31 | 15.45% |
| 2016-09-30 | 35.46% |
| 2016-06-30 | 31.45% |
| 2016-03-31 | 29.59% |
| 2015-12-31 | 27.19% |
| 2015-09-30 | 22.88% |
| 2015-06-30 | 0.04% |
| 2015-03-31 | 0.04% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 52.40% |
| 2002-12-31 | 194.83% |
| 2002-09-30 | 281.18% |
